| 09.30 – 10.00 |
Introduction into the issues by WIPO
- Antony Taubman, Acting Director and Head, Global IP Issues Division, WIPO [PDF]
|
| 10.00 – 10.30 |
Framing a national policy for managing intellectual property rights resulting from publicly financed research
- McLean Sibanda, Senior Patent Attorney, National Research Foundation, Pretoria, South Africa [PDF] [PDF]
|
| 10.30 – 11.00 |
Public interest intellectual property management and freedom of research
- Wolf-Michael Catenhusen, Former State Secretary, Federal Ministry of Education and Research, Berlin, Germany [PDF]
|
| 11.00 – 11.30 |
Coffee Break |
| 11.30 – 12.00 |
The policy guidelines on intellectual property of the International Centre for Genetic Engineering and Biotechnology (ICGEB)
- Decio M. Ripandelli, Director, Administration and External Relations, Secretary of the ICGEB Board of Governors, ICGEB, Trieste, Italy [PDF] [PDF]
|
| 12.00 – 12.30 |
Discussion |
| 12.30 – 14.00 |
Lunch Break |
| 14.00 – 15.00 |
Intellectual property management policy in public health research
- Raimundo Ubieta Gómez, Center for Genetic Engineering and Biotechnology, Havana, Cuba [PDF]
- Jack Spiegel (retired), Senior Advisor for Technology Transfer Operations, Office of Technology Transfer, National Institute of Health, USA [PDF] [PDF]
|
| 15.00 – 15.30 |
Coffee break |
| 15.30 – 16.00 |
Drug development through public private partnerships (PPP)
- Janis K. Lazdins, Leader, Drug Development and Evaluation for Helminths and other Neglected Tropical Diseases, Special Programme for Research and Training in Tropical Diseases, WHO, Geneva, Switzerland [PDF]
|
| 16.00 – 17.00 |
An appropriate strategy for managing existing and developed intellectual property rights
- Sylvie Fonteilles-Drabek, The Medicines for Malaria Venture, Geneva, Switzerland [PDF]
- Jean-Pierre Paccaud, Drugs for Neglected Diseases initiative, Geneva, Switzerland [PDF] [PDF]
|
| 17.00 – 17.30 |
Discussion |
